Bli medlem
Bli medlem

Du är här

2020-07-14

191,501 Orion Corporation A shares converted into B shares

ORION CORPORATION STOCK EXCHANGE RELEASE 14 JULY 2020 at 9.00 EEST             
         
191,501 Orion Corporation A shares converted into B shares

In accordance with Section 3 of the Articles of Association of Orion Corporation, 191,501 A shares have been converted into 191,501 B shares. The conversion has been entered into the Trade Register on 14 July 2020.

The total number of shares in Orion Corporation is 141,134,278 which, after the conversion, consists of 35,251,974 A shares and 105,882,304 B shares. The number of votes of the company's shares is after the conversion 810,921,784.

Orion Corporation

Jari Karlson
CFO
 Olli Huotari
SVP, Corporate Functions
 

                                                                                                                                   
Contact person:
Tuukka Hirvonen, Investor Relations, tel. +358 10 426 2721


Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
www.orion.fi

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS) disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs. Orion's net sales in 2019 amounted to EUR 1,051 million and the company had about 3,300 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.

Författare Orion Oyj

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.